HEADER TRANSCRIPTION/TRANSCRIPTION INHIBITOR 18-MAY-18 6DGR TITLE CRYSTAL STRUCTURE OF HUMAN PPARGAMMA LIGAND BINDING DOMAIN IN COMPLEX TITLE 2 WITH CAY10638 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PPAR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET46 KEYWDS NUCLEAR RECEPTORS, TZDS, DRUG DESIGN, THERAPEUTIC TARGETS, KEYWDS 2 TRANSCRIPTION, TRANSCRIPTION-TRANSCRIPTION INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.SHANG,D.J.KOJETIN REVDAT 4 11-OCT-23 6DGR 1 REMARK REVDAT 3 25-DEC-19 6DGR 1 REMARK REVDAT 2 06-NOV-19 6DGR 1 JRNL REVDAT 1 22-MAY-19 6DGR 0 JRNL AUTH J.SHANG,R.BRUST,P.R.GRIFFIN,T.M.KAMENECKA,D.J.KOJETIN JRNL TITL QUANTITATIVE STRUCTURAL ASSESSMENT OF GRADED RECEPTOR JRNL TITL 2 AGONISM. JRNL REF PROC.NATL.ACAD.SCI.USA V. 116 22179 2019 JRNL REFN ESSN 1091-6490 JRNL PMID 31611383 JRNL DOI 10.1073/PNAS.1909016116 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.11.1_2575: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.34 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.310 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 3 NUMBER OF REFLECTIONS : 33634 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.950 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 50.3553 - 5.1801 0.99 2412 152 0.1951 0.2325 REMARK 3 2 5.1801 - 4.1122 0.98 2324 147 0.1723 0.2204 REMARK 3 3 4.1122 - 3.5926 0.99 2339 148 0.1738 0.1990 REMARK 3 4 3.5926 - 3.2642 0.99 2308 147 0.1915 0.2243 REMARK 3 5 3.2642 - 3.0302 0.98 2299 144 0.2152 0.2893 REMARK 3 6 3.0302 - 2.8516 0.99 2312 147 0.2244 0.3012 REMARK 3 7 2.8516 - 2.7088 0.98 2302 145 0.2256 0.3040 REMARK 3 8 2.7088 - 2.5909 0.94 2183 139 0.2310 0.2759 REMARK 3 9 2.5909 - 2.4911 0.96 2220 139 0.2390 0.2964 REMARK 3 10 2.4911 - 2.4052 0.97 2237 142 0.2418 0.3338 REMARK 3 11 2.4052 - 2.3300 0.95 2222 140 0.2579 0.2826 REMARK 3 12 2.3300 - 2.2634 0.92 2157 137 0.2822 0.3474 REMARK 3 13 2.2634 - 2.2038 0.93 2158 137 0.3093 0.3618 REMARK 3 14 2.2038 - 2.1500 0.93 2161 136 0.3190 0.3313 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.730 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4424 REMARK 3 ANGLE : 1.036 5960 REMARK 3 CHIRALITY : 0.051 690 REMARK 3 PLANARITY : 0.007 754 REMARK 3 DIHEDRAL : 3.704 2726 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6DGR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1000234574. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-APR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97741 REMARK 200 MONOCHROMATOR : DOUBLE-CRYSTAL, SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33678 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 50.340 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 200 DATA REDUNDANCY : 1.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.8400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.9 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.340 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1PRG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.88 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.8M SODIUM CITRATE, 100MM TRIS, PH REMARK 280 7.6, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 46.43050 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 30.30000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 46.43050 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 30.30000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 181 REMARK 465 ALA A 182 REMARK 465 HIS A 183 REMARK 465 HIS A 184 REMARK 465 HIS A 185 REMARK 465 HIS A 186 REMARK 465 HIS A 187 REMARK 465 HIS A 188 REMARK 465 VAL A 189 REMARK 465 ASP A 190 REMARK 465 ASP A 191 REMARK 465 ASP A 192 REMARK 465 ASP A 193 REMARK 465 LYS A 194 REMARK 465 MET A 195 REMARK 465 GLU A 196 REMARK 465 ASN A 197 REMARK 465 LEU A 198 REMARK 465 TYR A 199 REMARK 465 PHE A 200 REMARK 465 GLN A 201 REMARK 465 GLY A 202 REMARK 465 GLN A 203 REMARK 465 LEU A 204 REMARK 465 ASN A 205 REMARK 465 PRO A 206 REMARK 465 ILE A 267 REMARK 465 THR A 268 REMARK 465 PRO A 269 REMARK 465 LEU A 270 REMARK 465 GLN A 271 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 SER A 274 REMARK 465 LYS A 275 REMARK 465 TYR A 477 REMARK 465 MET B 181 REMARK 465 ALA B 182 REMARK 465 HIS B 183 REMARK 465 HIS B 184 REMARK 465 HIS B 185 REMARK 465 HIS B 186 REMARK 465 HIS B 187 REMARK 465 HIS B 188 REMARK 465 VAL B 189 REMARK 465 ASP B 190 REMARK 465 ASP B 191 REMARK 465 ASP B 192 REMARK 465 ASP B 193 REMARK 465 LYS B 194 REMARK 465 MET B 195 REMARK 465 GLU B 196 REMARK 465 ASN B 197 REMARK 465 LEU B 198 REMARK 465 TYR B 199 REMARK 465 PHE B 200 REMARK 465 GLN B 201 REMARK 465 GLY B 202 REMARK 465 GLN B 203 REMARK 465 LEU B 204 REMARK 465 ASN B 205 REMARK 465 PRO B 206 REMARK 465 THR B 241 REMARK 465 THR B 242 REMARK 465 ASP B 243 REMARK 465 ILE B 262 REMARK 465 LYS B 263 REMARK 465 PHE B 264 REMARK 465 THR B 268 REMARK 465 PRO B 269 REMARK 465 LEU B 270 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 GLN B 273 REMARK 465 SER B 274 REMARK 465 MET B 463 REMARK 465 SER B 464 REMARK 465 LEU B 465 REMARK 465 TYR B 477 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 265 62.51 -156.19 REMARK 500 ASP A 310 130.53 -39.93 REMARK 500 LYS A 358 -111.97 40.64 REMARK 500 PRO A 359 -70.07 -40.87 REMARK 500 PHE A 360 -17.29 -48.78 REMARK 500 LEU A 393 55.71 -95.00 REMARK 500 TYR A 473 41.78 -69.74 REMARK 500 ASP A 475 -125.00 36.45 REMARK 500 SER B 208 2.50 -61.82 REMARK 500 LEU B 237 -144.37 -60.62 REMARK 500 THR B 238 83.41 -50.37 REMARK 500 HIS B 266 -166.53 -79.15 REMARK 500 LYS B 358 -136.59 48.94 REMARK 500 LYS B 458 34.98 -96.02 REMARK 500 THR B 459 -61.70 -127.47 REMARK 500 THR B 461 -148.59 -115.14 REMARK 500 PRO B 467 -64.04 7.85 REMARK 500 TYR B 473 64.50 -101.08 REMARK 500 ASP B 475 -37.51 179.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 727 DISTANCE = 6.34 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GDY A 501 DBREF 6DGR A 203 477 UNP P37231 PPARG_HUMAN 231 505 DBREF 6DGR B 203 477 UNP P37231 PPARG_HUMAN 231 505 SEQADV 6DGR MET A 181 UNP P37231 INITIATING METHIONINE SEQADV 6DGR ALA A 182 UNP P37231 EXPRESSION TAG SEQADV 6DGR HIS A 183 UNP P37231 EXPRESSION TAG SEQADV 6DGR HIS A 184 UNP P37231 EXPRESSION TAG SEQADV 6DGR HIS A 185 UNP P37231 EXPRESSION TAG SEQADV 6DGR HIS A 186 UNP P37231 EXPRESSION TAG SEQADV 6DGR HIS A 187 UNP P37231 EXPRESSION TAG SEQADV 6DGR HIS A 188 UNP P37231 EXPRESSION TAG SEQADV 6DGR VAL A 189 UNP P37231 EXPRESSION TAG SEQADV 6DGR ASP A 190 UNP P37231 EXPRESSION TAG SEQADV 6DGR ASP A 191 UNP P37231 EXPRESSION TAG SEQADV 6DGR ASP A 192 UNP P37231 EXPRESSION TAG SEQADV 6DGR ASP A 193 UNP P37231 EXPRESSION TAG SEQADV 6DGR LYS A 194 UNP P37231 EXPRESSION TAG SEQADV 6DGR MET A 195 UNP P37231 EXPRESSION TAG SEQADV 6DGR GLU A 196 UNP P37231 EXPRESSION TAG SEQADV 6DGR ASN A 197 UNP P37231 EXPRESSION TAG SEQADV 6DGR LEU A 198 UNP P37231 EXPRESSION TAG SEQADV 6DGR TYR A 199 UNP P37231 EXPRESSION TAG SEQADV 6DGR PHE A 200 UNP P37231 EXPRESSION TAG SEQADV 6DGR GLN A 201 UNP P37231 EXPRESSION TAG SEQADV 6DGR GLY A 202 UNP P37231 EXPRESSION TAG SEQADV 6DGR MET B 181 UNP P37231 INITIATING METHIONINE SEQADV 6DGR ALA B 182 UNP P37231 EXPRESSION TAG SEQADV 6DGR HIS B 183 UNP P37231 EXPRESSION TAG SEQADV 6DGR HIS B 184 UNP P37231 EXPRESSION TAG SEQADV 6DGR HIS B 185 UNP P37231 EXPRESSION TAG SEQADV 6DGR HIS B 186 UNP P37231 EXPRESSION TAG SEQADV 6DGR HIS B 187 UNP P37231 EXPRESSION TAG SEQADV 6DGR HIS B 188 UNP P37231 EXPRESSION TAG SEQADV 6DGR VAL B 189 UNP P37231 EXPRESSION TAG SEQADV 6DGR ASP B 190 UNP P37231 EXPRESSION TAG SEQADV 6DGR ASP B 191 UNP P37231 EXPRESSION TAG SEQADV 6DGR ASP B 192 UNP P37231 EXPRESSION TAG SEQADV 6DGR ASP B 193 UNP P37231 EXPRESSION TAG SEQADV 6DGR LYS B 194 UNP P37231 EXPRESSION TAG SEQADV 6DGR MET B 195 UNP P37231 EXPRESSION TAG SEQADV 6DGR GLU B 196 UNP P37231 EXPRESSION TAG SEQADV 6DGR ASN B 197 UNP P37231 EXPRESSION TAG SEQADV 6DGR LEU B 198 UNP P37231 EXPRESSION TAG SEQADV 6DGR TYR B 199 UNP P37231 EXPRESSION TAG SEQADV 6DGR PHE B 200 UNP P37231 EXPRESSION TAG SEQADV 6DGR GLN B 201 UNP P37231 EXPRESSION TAG SEQADV 6DGR GLY B 202 UNP P37231 EXPRESSION TAG SEQRES 1 A 297 MET ALA HIS HIS HIS HIS HIS HIS VAL ASP ASP ASP ASP SEQRES 2 A 297 LYS MET GLU ASN LEU TYR PHE GLN GLY GLN LEU ASN PRO SEQRES 3 A 297 GLU SER ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU TYR SEQRES 4 A 297 ASP SER TYR ILE LYS SER PHE PRO LEU THR LYS ALA LYS SEQRES 5 A 297 ALA ARG ALA ILE LEU THR GLY LYS THR THR ASP LYS SER SEQRES 6 A 297 PRO PHE VAL ILE TYR ASP MET ASN SER LEU MET MET GLY SEQRES 7 A 297 GLU ASP LYS ILE LYS PHE LYS HIS ILE THR PRO LEU GLN SEQRES 8 A 297 GLU GLN SER LYS GLU VAL ALA ILE ARG ILE PHE GLN GLY SEQRES 9 A 297 CYS GLN PHE ARG SER VAL GLU ALA VAL GLN GLU ILE THR SEQRES 10 A 297 GLU TYR ALA LYS SER ILE PRO GLY PHE VAL ASN LEU ASP SEQRES 11 A 297 LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS SEQRES 12 A 297 GLU ILE ILE TYR THR MET LEU ALA SER LEU MET ASN LYS SEQRES 13 A 297 ASP GLY VAL LEU ILE SER GLU GLY GLN GLY PHE MET THR SEQRES 14 A 297 ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE GLY ASP SEQRES 15 A 297 PHE MET GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN SEQRES 16 A 297 ALA LEU GLU LEU ASP ASP SER ASP LEU ALA ILE PHE ILE SEQRES 17 A 297 ALA VAL ILE ILE LEU SER GLY ASP ARG PRO GLY LEU LEU SEQRES 18 A 297 ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU LEU SEQRES 19 A 297 GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO GLU SEQRES 20 A 297 SER SER GLN LEU PHE ALA LYS LEU LEU GLN LYS MET THR SEQRES 21 A 297 ASP LEU ARG GLN ILE VAL THR GLU HIS VAL GLN LEU LEU SEQRES 22 A 297 GLN VAL ILE LYS LYS THR GLU THR ASP MET SER LEU HIS SEQRES 23 A 297 PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU TYR SEQRES 1 B 297 MET ALA HIS HIS HIS HIS HIS HIS VAL ASP ASP ASP ASP SEQRES 2 B 297 LYS MET GLU ASN LEU TYR PHE GLN GLY GLN LEU ASN PRO SEQRES 3 B 297 GLU SER ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU TYR SEQRES 4 B 297 ASP SER TYR ILE LYS SER PHE PRO LEU THR LYS ALA LYS SEQRES 5 B 297 ALA ARG ALA ILE LEU THR GLY LYS THR THR ASP LYS SER SEQRES 6 B 297 PRO PHE VAL ILE TYR ASP MET ASN SER LEU MET MET GLY SEQRES 7 B 297 GLU ASP LYS ILE LYS PHE LYS HIS ILE THR PRO LEU GLN SEQRES 8 B 297 GLU GLN SER LYS GLU VAL ALA ILE ARG ILE PHE GLN GLY SEQRES 9 B 297 CYS GLN PHE ARG SER VAL GLU ALA VAL GLN GLU ILE THR SEQRES 10 B 297 GLU TYR ALA LYS SER ILE PRO GLY PHE VAL ASN LEU ASP SEQRES 11 B 297 LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS SEQRES 12 B 297 GLU ILE ILE TYR THR MET LEU ALA SER LEU MET ASN LYS SEQRES 13 B 297 ASP GLY VAL LEU ILE SER GLU GLY GLN GLY PHE MET THR SEQRES 14 B 297 ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE GLY ASP SEQRES 15 B 297 PHE MET GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN SEQRES 16 B 297 ALA LEU GLU LEU ASP ASP SER ASP LEU ALA ILE PHE ILE SEQRES 17 B 297 ALA VAL ILE ILE LEU SER GLY ASP ARG PRO GLY LEU LEU SEQRES 18 B 297 ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU LEU SEQRES 19 B 297 GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO GLU SEQRES 20 B 297 SER SER GLN LEU PHE ALA LYS LEU LEU GLN LYS MET THR SEQRES 21 B 297 ASP LEU ARG GLN ILE VAL THR GLU HIS VAL GLN LEU LEU SEQRES 22 B 297 GLN VAL ILE LYS LYS THR GLU THR ASP MET SER LEU HIS SEQRES 23 B 297 PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU TYR HET GDY A 501 22 HETNAM GDY (5Z)-5-({4-[2-(THIOPHEN-2-YL) HETNAM 2 GDY ETHOXY]PHENYL}METHYLIDENE)-1,3-THIAZOLIDINE-2,4-DIONE FORMUL 3 GDY C16 H13 N O3 S2 FORMUL 4 HOH *226(H2 O) HELIX 1 AA1 GLU A 207 PHE A 226 1 20 HELIX 2 AA2 THR A 229 GLY A 239 1 11 HELIX 3 AA3 ASP A 251 ILE A 262 1 12 HELIX 4 AA4 VAL A 277 ILE A 303 1 27 HELIX 5 AA5 ASP A 310 ALA A 331 1 22 HELIX 6 AA6 ARG A 350 SER A 355 1 6 HELIX 7 AA7 ARG A 357 PHE A 363 5 7 HELIX 8 AA8 MET A 364 ASN A 375 1 12 HELIX 9 AA9 ALA A 376 GLU A 378 5 3 HELIX 10 AB1 ASP A 380 LEU A 393 1 14 HELIX 11 AB2 ASN A 402 HIS A 425 1 24 HELIX 12 AB3 GLN A 430 GLU A 460 1 31 HELIX 13 AB4 HIS A 466 TYR A 473 1 8 HELIX 14 AB5 SER B 208 PHE B 226 1 19 HELIX 15 AB6 THR B 229 LEU B 237 1 9 HELIX 16 AB7 ASP B 251 LYS B 261 1 11 HELIX 17 AB8 GLU B 276 SER B 302 1 27 HELIX 18 AB9 ASP B 310 SER B 332 1 23 HELIX 19 AC1 ARG B 350 SER B 355 1 6 HELIX 20 AC2 PRO B 359 PHE B 363 5 5 HELIX 21 AC3 MET B 364 ALA B 376 1 13 HELIX 22 AC4 ASP B 380 LEU B 393 1 14 HELIX 23 AC5 ASN B 402 HIS B 425 1 24 HELIX 24 AC6 GLN B 430 LYS B 458 1 29 HELIX 25 AC7 PRO B 467 TYR B 473 1 7 SHEET 1 AA1 4 PHE A 247 ILE A 249 0 SHEET 2 AA1 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 AA1 4 GLY A 338 ILE A 341 -1 N VAL A 339 O MET A 348 SHEET 4 AA1 4 MET A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 SHEET 1 AA2 4 PHE B 247 ILE B 249 0 SHEET 2 AA2 4 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249 SHEET 3 AA2 4 GLY B 338 ILE B 341 -1 N VAL B 339 O MET B 348 SHEET 4 AA2 4 MET B 334 ASN B 335 -1 N ASN B 335 O GLY B 338 SITE 1 AC1 8 PHE A 282 CYS A 285 SER A 289 HIS A 323 SITE 2 AC1 8 ILE A 341 MET A 364 HIS A 449 TYR A 473 CRYST1 92.861 60.600 117.660 90.00 103.14 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010769 0.000000 0.002514 0.00000 SCALE2 0.000000 0.016502 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008728 0.00000